Bioliberty

Raised $8.2M in a Series A round, announced 18 March 2026.

Total raised
$8.2M

Latest round Series ACountry United KingdomSector Health

Round

$8.2MSeries A, 18 March 2026

Series A anchored by a $4M investment from the Scottish National Investment Bank to commercialize its Lifehub platform in the US.

Update 2 November 2026 Adds $3.3 million to its existing Series A round. news.google.com

Amount
$8.2M
Stage
Series A
Announced
18 March 2026
Lead
Scottish National Investment Bank
Other investors
Archangels, Eos Advisory, Old College Capital, Hanna Capital SEZC, Conduit Connect
Use of funds
Series A anchored by a $4M investment from the Scottish National Investment Bank to commercialize its Lifehub platform in the US.
Checked
Announced by the company
Sources
Bioliberty raises $10.2M for post-acute care functional intelligence daytraders.com
Bioliberty raises $10.2M for post-acute care functional intelligence pulse2.com
Newsletter Startup rounds, in your inbox.

Free. Unsubscribe anytime.

Company

Functional intelligence platform and robotic glove for post-acute rehabilitation care

Based in
Edinburgh, United Kingdom
Sector
Health
Website
bioliberty.com ↗

Links

Website
bioliberty.com ↗

Questions

How much has Bioliberty raised?

Bioliberty raised $8.2M in a Series A round, announced on 18 March 2026.

Who invested in Bioliberty?

Scottish National Investment Bank led. Investors include Scottish National Investment Bank, Archangels, Eos Advisory, Old College Capital, Hanna Capital SEZC and Conduit Connect.